Gumisad, Richen, N/A. B.
HRN: 21-74-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/17/2023
04/24/2023
IV
4.5 G
Q6
Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes